These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 12236)
21. Experimental recurrent pneumococcal otitis media. Protection and serum antibodies. Svinhufvud M; Prellner K; Hermansson A; Schalén C Acta Otolaryngol; 1991; 111(6):1083-9. PubMed ID: 1763630 [TBL] [Abstract][Full Text] [Related]
22. Effect of tympanostomy tubes on the pathogenesis of acute otitis media. Meyerhoff WL; Giebink GS; Shea DA; Le CT Am J Otolaryngol; 1982; 3(3):189-95. PubMed ID: 7102957 [TBL] [Abstract][Full Text] [Related]
23. Expression of intercellular adhesion molecule-1 in rat inner ear due to bacterial otitis media. Sone M; Russlie HQ; Canafax DM; Paparella MM Ann Otol Rhinol Laryngol; 1999 Jul; 108(7 Pt 1):648-52. PubMed ID: 10435922 [TBL] [Abstract][Full Text] [Related]
25. Effect of Streptococcus pneumoniae and influenza A virus on middle ear antimicrobial pharmacokinetics in experimental otitis media. Jossart GH; Canafax DM; Erdmann GR; Lovdahl MJ; Russlie HQ; Juhn SK; Giebink GS Pharm Res; 1994 Jun; 11(6):860-4. PubMed ID: 7937526 [TBL] [Abstract][Full Text] [Related]
26. Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model. Xu Q; Pryharski K; Pichichero ME Vaccine; 2017 Jan; 35(2):337-344. PubMed ID: 27919628 [TBL] [Abstract][Full Text] [Related]
27. Biochemical and immunochemical characteristics of middle ear effusions in relation to bacteriological findings. Juhn SK; Giebink GS; Huff JS; Mills EL Ann Otol Rhinol Laryngol Suppl; 1980; 89(3 Pt 2):161-7. PubMed ID: 6778300 [TBL] [Abstract][Full Text] [Related]
28. Roles of autolysin and pneumolysin in middle ear inflammation caused by a type 3 Streptococcus pneumoniae strain in the chinchilla otitis media model. Sato K; Quartey MK; Liebeler CL; Le CT; Giebink GS Infect Immun; 1996 Apr; 64(4):1140-5. PubMed ID: 8606070 [TBL] [Abstract][Full Text] [Related]
29. Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media. Keller LE; Bradshaw JL; Pipkins H; McDaniel LS Front Cell Infect Microbiol; 2016; 6():55. PubMed ID: 27242973 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of a novel oral carbapenem, tebipenem pivoxil (TBM-PI), against experimental otitis media caused by penicillin resistant Streptococcus pneumoniae in chinchilla. Hotomi M; Suzumoto M; Itahashi K; Nagura J; Fukushima T; Shimada J; Billal DS; Yamauchi K; Fujihara K; Yamanaka N Vaccine; 2007 Mar; 25(13):2478-84. PubMed ID: 17055132 [TBL] [Abstract][Full Text] [Related]
31. Comparison of alteration of cell surface carbohydrates of the chinchilla tubotympanum and colonial opacity phenotype of Streptococcus pneumoniae during experimental pneumococcal otitis media with or without an antecedent influenza A virus infection. Tong HH; Grants I; Liu X; DeMaria TF Infect Immun; 2002 Aug; 70(8):4292-301. PubMed ID: 12117938 [TBL] [Abstract][Full Text] [Related]
32. Capsular switching as a strategy to increase pneumococcal virulence in experimental otitis media model. Sabharwal V; Stevenson A; Figueira M; Orthopoulos G; Trzciński K; Pelton SI Microbes Infect; 2014 Apr; 16(4):292-9. PubMed ID: 24361902 [TBL] [Abstract][Full Text] [Related]
33. Microdialysis studies of the middle ear distribution kinetics of amoxicillin in the awake chinchilla. Huang Y; Ji P; Inano A; Yang Z; Giebink GS; Sawchuk RJ J Pharm Sci; 2001 Dec; 90(12):2088-98. PubMed ID: 11745767 [TBL] [Abstract][Full Text] [Related]
34. Role of pneumococcal proteins in sensorineural hearing loss due to otitis media. Tsuprun V; Cureoglu S; Schachern PA; Ferrieri P; Briles DE; Paparella MM; Juhn SK Otol Neurotol; 2008 Dec; 29(8):1056-60. PubMed ID: 18833010 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae. Figueira M; Fernandes P; Pelton SI Antimicrob Agents Chemother; 2016 Sep; 60(9):5533-8. PubMed ID: 27401563 [TBL] [Abstract][Full Text] [Related]
36. Development of myringosclerosis during acute otitis media caused by Streptococcus pneumoniae and non-typeable Haemophilus influenzae: a clinical otomicroscopical study using the rat model. Raustyte G; Hermansson A Medicina (Kaunas); 2005; 41(8):661-7. PubMed ID: 16160414 [TBL] [Abstract][Full Text] [Related]
37. Correlation of higher antibody levels to pneumococcal proteins with protection from pneumococcal acute otitis media but not protection from nasopharyngeal colonization in young children. Xu Q; Casey JR; Almudevar A; Pichichero ME Clin Microbiol Infect; 2017 Jul; 23(7):487.e1-487.e6. PubMed ID: 28143785 [TBL] [Abstract][Full Text] [Related]
38. Pathophysiology of Streptococcus pneumoniae otitis media: kinetics of the middle ear biochemical and cytologic host responses. Nonomura N; Giebink GS; Juhn SK; Harada T; Aeppli D Ann Otol Rhinol Laryngol; 1991 Mar; 100(3):236-43. PubMed ID: 1706582 [TBL] [Abstract][Full Text] [Related]
39. Changes in the structure of the cell surface carbohydrates of the chinchilla tubotympanum following Streptococcus pneumoniae-induced otitis media. Linder TE; Lim DJ; DeMaria TF Microb Pathog; 1992 Oct; 13(4):293-303. PubMed ID: 1298868 [TBL] [Abstract][Full Text] [Related]
40. Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children. Ren D; Almudevar AL; Pichichero ME Hum Vaccin Immunother; 2015; 11(2):489-97. PubMed ID: 25692218 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]